Clrb stock price target
CLRB Stock Quote of Cellectar Biosc Check out our CLRB stock analysis, current CLRB quote, charts, and historical prices for Cellectar Biosc stock. Research Report) today and set a price target of $3.00. The company’s shares CLRB Historical Stock Prices Cellectar Biosciences (CLRB) has the following price history information. Looking back at CLRB historical stock prices for the last five trading days, on March 23, 2020, CLRB opened at $1.15, traded as high as $1.19 and as low as $1.07, and closed at … Cellectar Biosciences (NASDAQ:CLRB) Stock Rating ... Cellectar Biosciences (NASDAQ:CLRB) ‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Wednesday, AnalystRatings.com reports. They presently have a $3.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price objective indicates a potential upside of 175.23% from the stock’s previous close. Cellectar Biosciences (NASDAQ:CLRB) Stock Rating ...
Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR …
CLRB Stock Price, Forecast & News (Cellectar Biosciences) Analyzing Cellectar Biosciences (NASDAQ:CLRB) stock? View CLRB's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote ... Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital information to help you with your stock trading and investing. CLRB Cellectar Biosciences, Inc. — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss …
Analysts Turn Mixed On Ball Corporation (NYSE:BLL ...
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss … CLRB | Cellectar Biosciences Inc. Analyst Estimates ... Nov 06, 2019 · Cellectar Biosciences Inc. analyst estimates by MarketWatch. View CLRB revenue estimates and earnings estimates, as well as analyst recommendations.
Based on analysts offering 12 month price targets for CLRB in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your
Cellectar Biosciences (NASDAQ:CLRB) Stock Rating ...
Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update. FLORHAM PARK, N.J., March 09, 2020 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and.
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss … CLRB | Cellectar Biosciences Inc. Analyst Estimates ...
Cellectar Biosciences, Inc quote is equal to 1.190 USD at 2020-04-07. Based on our forecasts, a long-term increase is expected, the "CLRB" stock price prognosis